Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
NLRC4-mediated activation of CD1c+ DC contributes to perpetuation of synovitis in rheumatoid arthritis
Cristina Delgado-Arévalo, … , Isidoro González Álvaro, Enrique Martin-Gayo
Cristina Delgado-Arévalo, … , Isidoro González Álvaro, Enrique Martin-Gayo
Published October 4, 2022
Citation Information: JCI Insight. 2022;7(22):e152886. https://doi.org/10.1172/jci.insight.152886.
View: Text | PDF
Research Article Cell biology

NLRC4-mediated activation of CD1c+ DC contributes to perpetuation of synovitis in rheumatoid arthritis

  • Text
  • PDF
Abstract

The individual contribution of specific myeloid subsets such as CD1c+ conventional DC (cDC) to perpetuation of rheumatoid arthritis (RA) pathology remains unclear. In addition, the specific innate sensors driving pathogenic activation of CD1c+ cDC in patients with RA and their functional implications have not been characterized. Here, we assessed phenotypical, transcriptional, and functional characteristics of CD1c+ and CD141+ cDC and monocytes from the blood and synovial fluid of patients with RA. Increased levels of CCR2 and the IgG receptor CD64 on circulating CD1c+ cDC was associated with the presence of this DC subset in the synovial membrane in patients with RA. Moreover, synovial CD1c+ cDC are characterized by increased expression of proinflammatory cytokines and high abilities to induce pathogenic IFN-γ+IL-17+CD4+ T cells in vitro. Finally, we identified the crosstalk between Fcγ receptors and NLRC4 as a potential molecular mechanism mediating pathogenic activation, CD64 upregulation, and functional specialization of CD1c+ cDC in response to dsDNA-IgG in patients with RA.

Authors

Cristina Delgado-Arévalo, Marta Calvet-Mirabent, Ana Triguero-Martínez, Enrique Vázquez de Luis, Alberto Benguría-Filippini, Raquel Largo, Diego Calzada-Fraile, Olga Popova, Ildefonso Sánchez-Cerrillo, Ilya Tsukalov, Roberto Moreno-Vellisca, Hortensia de la Fuente, Gabriel Herrero-Beaumont, Almudena Ramiro, Francisco Sánchez-Madrid, Santos Castañeda, Ana Dopazo, Isidoro González Álvaro, Enrique Martin-Gayo

×

Figure 7

Identification of NLRC4 as the sensor potentially driving pathogenic activation of CD1c+ cDC in patients with RA.

Options: View larger image (or click on image) Download as PowerPoint
Identification of NLRC4 as the sensor potentially driving pathogenic act...
(A) Heatmap representing log2FC in transcription of 18 inflammasome genes on each sorted myeloid cell subset from the peripheral blood (PB) from n = 4 RA versus n = 4 healthy controls (HC) (red, upregulated; blue, downregulated). Size of yellow dots is proportional to statistical significance between PB RA and healthy donors (FDR-corrected P < 0.05). (B) Venn diagram showing overlap of DEG associated with the inflammasome by IPA in the indicated myeloid cell subsets from the PB of n = 4 patients with RA compared with n = 4 healthy donors. (C) Gene network including significantly upregulated (red) or downregulated (blue) DEG inflammasome genes in PB CD1c+ cDC from patients with RA compared with HC (right). Individual (purple) and connected target genes (red) are shown. (D) mRNA expression of NLRC4 (left plot) and NLRP3 (right plot) relative to β-actin validated by qPCR in sorted CD1c+ cDC from n = 5 patients with RA and n = 4 HC individuals. Statistical significance was calculated with a 2-tailed Mann Whitney U test. *P < 0.05. (E) Unsupervised heatmap reflecting normalized expression levels of the indicated inflammasome sensors in Mo, CD1c+ cDC, and CD141+ cDC from n = 3 SF of patients with RA versus the same myeloid subsets from the blood of n = 4 HC. (F–H) Fold change on IL-1β and CCL3 mRNA expression relative to β-actin mRNA levels analyzed by qPCR (F), on surface expression of CD64 (G), and on functional ability to induce pathogenic IFN-γ+IL-17+ cells (H) in CD1c+ cDC nucleofected with indicated siRNAs and cultured in media or in the presence of IgG-dsDNA complexes (n = 7 experiments). Statistical significance was calculated using a 2-tailed Wilcoxon matched-pairs test. *P < 0.05.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts